REFILE-Teva's turnaround CEO sets sights on $40 bln mega-deal By: Reuters: Company News April 22, 2015 at 09:10 AM EDT * Mega-deal follows several large acquisitions in last two decades Read More >> Related Stocks: Mylan Teva Pharmaceutical Industries ADR